Olanzapine and Deep vein thrombosis - from FDA reports


Summary

Deep vein thrombosis is found among people who take Olanzapine, especially for people who are male, 60+ old , have been taking the drug for 1 - 6 months, also take medication Spiriva, and have Schizophrenia . We study 19,861 people who have side effects while taking Olanzapine from FDA. Among them, 175 have Deep vein thrombosis. Find out below who they are, when they have Deep vein thrombosis and more.

What to expect?

If you take Olanzapine and have Deep vein thrombosis, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Olanzapine and have Deep vein thrombosis

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Olanzapine

Olanzapine has active ingredients of olanzapine. It is often used in bipolar disorder. (latest outcomes from Olanzapine 20,291 users)

Deep Vein Thrombosis

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis) has been reported by people with birth control, multiple myeloma, pain, deep venous thrombosis, high blood pressure (latest reports from 72,260 Deep vein thrombosis patients).

On Feb, 01, 2017

19,861 people reported to have side effects when taking Olanzapine.
Among them, 175 people (0.88%) have Deep Vein Thrombosis


Number of reports submitted per year:

Could Olanzapine cause Deep vein thrombosis?

Time on Olanzapine when people have Deep Vein Thrombosis *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 42.11 %
  • 6 - 12 months: 5.26 %
  • 1 - 2 years: 31.58 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 21.05 %

Gender of people who have Deep Vein Thrombosis when taking Olanzapine *:

  • female: 37.5 %
  • male: 62.5 %

Age of people who have Deep Vein Thrombosis when taking Olanzapine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 2.07 %
  • 20-29: 16.55 %
  • 30-39: 16.55 %
  • 40-49: 17.24 %
  • 50-59: 17.93 %
  • 60+: 29.66 %

Top conditions involved for these people *:

  • Schizophrenia (26 people, 14.86%)
  • Depression (19 people, 10.86%)
  • Psychotic Disorder (11 people, 6.29%)
  • Gilles De La Tourette Syndrome (10 people, 5.71%)
  • Schizoaffective Disorder (7 people, 4.00%)

Top co-used drugs for these people *:

  • Spiriva (20 people, 11.43%)
  • Revlimid (14 people, 8.00%)
  • Lorazepam (14 people, 8.00%)
  • Ativan (14 people, 8.00%)
  • Albuterol (13 people, 7.43%)

Top other side effects for these people *:

  • Pulmonary Embolism (67 people, 38.29%)
  • Pneumonia (24 people, 13.71%)
  • Oedema Peripheral (22 people, 12.57%)
  • Lung Disorder (18 people, 10.29%)
  • Fever (18 people, 10.29%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Deep vein thrombosis when taking Olanzapine?

Browse all side effects of Olanzapine

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Deep vein thrombosis

Deep vein thrombosis

Could your condition cause Deep vein thrombosis

Deep vein thrombosis

Related studies

Can you answer these questions?

More questions for: Olanzapine, Deep vein thrombosis

You may be interested in these reviews

More reviews for: Olanzapine, Deep vein thrombosis